MedPath
FDA Approval

Terbinafine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
REMEDYREPACK INC.
DUNS: 829572556
Effective Date
February 17, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Terbinafine(250 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Terbinafine

Product Details

NDC Product Code
70518-1191
Application Number
ANDA077533
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
February 17, 2022
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
Code: 012C11ZU6GClass: ACTIMQuantity: 250 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath